HiFiBiO Therapeutics is a biotherapeutics company. The company integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies. It allows discovering and advancing a pipeline of antibody drugs to treat cancer and autoimmune disorders.
|Employees (est.) (Sept 2021)||77||(+7%)|
HiFiBiO Therapeutics total Funding
HiFiBiO Therapeutics latest funding size
Time since last funding
|3 months ago|
HiFiBiO Therapeutics investors
|Viventures, Legend Star, B Capital Group, Maison Capital, IDG Capital, Sequoia, Nest.Bio Ventures, Sequoia Capital China, Sherpa, Delian Capital, IDG, Mirae Asset Financial Group, LYFE Capital, Proxima Ventures Ltd, VI Ventures, Kite Pharma, Hanne Capital, Further, Trinity Innovation Fund, Grand Mount, HKSTP Venture Fund, Hengxu|
HiFiBiO Therapeutics has 231 Twitter Followers. The number of followers has increased 2.1% month over month and increased 16.1% quarter over quarter
When was HiFiBiO Therapeutics founded?
HiFiBiO Therapeutics was founded in 2013.
Who are HiFiBiO Therapeutics key executives?
HiFiBiO Therapeutics's key executives are Liang Schweizer, Jeff He and Xuqiong Wu.
How many employees does HiFiBiO Therapeutics have?
HiFiBiO Therapeutics has 77 employees.
Who are HiFiBiO Therapeutics competitors?
Competitors of HiFiBiO Therapeutics include Sphere Fluidics, BioFactura and Respivant Sciences.
Where is HiFiBiO Therapeutics headquarters?
HiFiBiO Therapeutics headquarters is located at 29 Rue du Faubourg Saint-Jacques, Paris.
Where are HiFiBiO Therapeutics offices?
HiFiBiO Therapeutics has offices in Paris, Cambridge and Shanghai.
How many offices does HiFiBiO Therapeutics have?
HiFiBiO Therapeutics has 3 offices.
Receive alerts for 300+ data fields across thousands of companies